Your browser doesn't support javascript.
loading
Low-Dose Alteplase During Primary Percutaneous Coronary Intervention According to Ischemic Time.
McCartney, Peter J; Maznyczka, Annette M; Eteiba, Hany; McEntegart, Margaret; Oldroyd, Keith G; Greenwood, John P; Maredia, Neil; Schmitt, Matthias; McCann, Gerry P; Fairbairn, Timothy; McAlindon, Elisa; Tait, Campbell; Welsh, Paul; Sattar, Naveed; Orchard, Vanessa; Corcoran, David; Ford, Thomas J; Radjenovic, Aleksandra; Ford, Ian; McConnachie, Alex; Berry, Colin.
Affiliation
  • McCartney PJ; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom.
  • Maznyczka AM; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom.
  • Eteiba H; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom.
  • McEntegart M; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom.
  • Oldroyd KG; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom.
  • Greenwood JP; Leeds University and Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, United Kingdom.
  • Maredia N; South Tees Hospitals NHS Foundation Trust, Middlesbrough, United Kingdom.
  • Schmitt M; Manchester University NHS Foundation Trust, Manchester, United Kingdom.
  • McCann GP; University of Leicester and the National Institute for Health Research Leicester Biomedical Research Center, Leicester, United Kingdom.
  • Fairbairn T; Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, United Kingdom.
  • McAlindon E; New Cross Hospital, Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom.
  • Tait C; Department of Hematology, Royal Infirmary, Glasgow, United Kingdom.
  • Welsh P; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom.
  • Sattar N; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom.
  • Orchard V; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom.
  • Corcoran D; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom.
  • Ford TJ; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Gosford Hospital, Gosford, New South Wales, Australia.
  • Radjenovic A; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom.
  • Ford I; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
  • McConnachie A; Robertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom.
  • Berry C; British Heart Foundation Glasgow Cardiovascular Research Center, University of Glasgow, Glasgow, United Kingdom; West of Scotland Heart and Lung Center, Golden Jubilee National Hospital, Clydebank, United Kingdom. Electronic address: colin.berry@glasgow.ac.uk.
J Am Coll Cardiol ; 75(12): 1406-1421, 2020 03 31.
Article in En | MEDLINE | ID: mdl-32216909
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tissue Plasminogen Activator / Fibrinolytic Agents / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Tissue Plasminogen Activator / Fibrinolytic Agents / Percutaneous Coronary Intervention / ST Elevation Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Year: 2020 Type: Article